Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
B4GALNT2 pseudogene 1 (B4GALNT2P1) is a non-protein-coding genomic sequence located on human chromosome 17 and annotated as a pseudogene homologous to the functional beta-1,4-N-acetyl-galactosaminyltransferase 2 gene (B4GALNT2)[1][5]. Unlike the protein-coding B4GALNT2 gene, which encodes an enzyme central to the synthesis of the SDa blood group antigen and displays regulatory activity in cancer and other biological processes[2][3][4][6], B4GALNT2P1 does not produce protein or participate in known biochemical or disease pathways. It is not considered a drug target, biomarker, or functional receptor/enzyme/transporter. There is no evidence of its involvement in therapeutic intervention or biological mechanisms, and it should not be confused with B4GALNT2, the functional gene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on B4GALNT2 pseudogene 1 (B4GALNT2P1).